Literature DB >> 31053376

The Two-way Relationship Between Cancer and Atherosclerosis.

Sergio Raposeiras Roubín1, Alberto Cordero2.   

Abstract

In the last few years, there has been growing interest in the relationship between cancer and cardiovascular disease. The increase in life expectancy in both diseases has led to their frequent coexistence in the same patient, which can lead to adverse drug reactions that increase patient risk. This is especially relevant in the case of atherosclerosis, which seems to share a common pathophysiological substrate with cancer. In this review, we analyze these common risk factors, and specifically analyze the relationship between different cancer treatments with the risk of coronary or cerebrovascular disease, as well as the current scientific evidence on the possible relationship between antiplatelet therapy and cancer risk. We also review the incidence and prognosis of cancer in patients with atherosclerosis and vice versa, based on the information reported in the most recently published studies in the field of cardio-oncology.
Copyright © 2019 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Antiplatelet therapy; Ateroesclerosis; Atherosclerosis; Cancer; Cardiopatía isquémica; Cáncer; Fármacos antiagregantes; Ischemic heart disease

Mesh:

Substances:

Year:  2019        PMID: 31053376     DOI: 10.1016/j.rec.2018.12.010

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  7 in total

1.  Underestimated Ischemic Heart Disease in Major Adverse Cardiovascular Events after Septicemia Discharge.

Authors:  Chih-Chun Hsiao; Yao-Ming Huang; Yin-Han Chang; Hui-Chen Lin; Wu-Chien Chien; Chun-Gu Cheng; Chun-An Cheng
Journal:  Medicina (Kaunas)       Date:  2022-05-31       Impact factor: 2.948

Review 2.  Cancer-Associated Atherothrombosis: The Challenge.

Authors:  Jochanan E Naschitz
Journal:  Int J Angiol       Date:  2021-07-19

3.  MDM2-Mediated Ubiquitination of RXRβ Contributes to Mitochondrial Damage and Related Inflammation in Atherosclerosis.

Authors:  Yi Zeng; Ji Cao; Chun-Xia Li; Chun-Yan Wang; Ruo-Man Wu; Xiao-Le Xu
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

4.  Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.

Authors:  Liubing Hu; Jiyue Liu; Hideaki Shimada; Masaaki Ito; Kazuo Sugimoto; Takaki Hiwasa; Qinghua Zhou; Jianshuang Li; Si Shen; Hao Wang
Journal:  Front Oncol       Date:  2022-05-17       Impact factor: 5.738

5.  The Relationship Between Cancer and Functional and Structural Markers of Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis.

Authors:  Yuhong Diao; Zhixing Liu; Li Chen; Weiping Zhang; Dandan Sun
Journal:  Front Cardiovasc Med       Date:  2022-05-04

Review 6.  Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis.

Authors:  Lili Wang; Hongxia Li; Yuhan Tang; Ping Yao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-01       Impact factor: 5.555

7.  Association between the Severity of Coronary Artery Disease and Lung Cancer: A Pilot Cross-Sectional Study.

Authors:  Mingzhuang Sun; Qian Yang; Meng Li; Jing Jing; Hao Zhou; Yundai Chen; Shunying Hu
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.